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Activation of the spliceosome for splicing catalysis
requires the dissociation of U4 snRNA from the U4/
U6 snRNA duplex prior to the first step of splicing.
We characterize an evolutionarily conserved 15.5 kDa
protein of the HeLa [U4/U6·U5] tri-snRNP that binds
directly to the 5 stem–loop of U4 snRNA. This protein
shares a novel RNA recognition motif with several
RNP-associated proteins, which is essential, but not
sufficient for RNA binding. The 15.5kD protein binding
site on the U4 snRNA consists of an internal purine-
rich loop flanked by the stem of the 5 stem–loop and
a stem comprising two base pairs. Addition of an RNA
oligonucleotide comprising the 5 stem–loop of U4
snRNA (U4SL) to an in vitro splicing reaction blocked
the first step of pre-mRNA splicing. Interestingly,
spliceosomal C complex formation was inhibited while
B complexes accumulated. This indicates that the
15.5kD protein, and/or additional U4 snRNP proteins
associated with it, play an important role in the late
stage of spliceosome assembly, prior to step I of splicing
catalysis. Our finding that the 15.5kD protein also
efficiently binds to the 5 stem–loop of U4atac snRNA
indicates that it may be shared by the [U4atac/U6at-
ac·U5] tri-snRNP of the minor U12-type spliceosome.
Keywords: pre-mRNA splicing/RNA–protein interaction/
snRNPs/U4 snRNA
Introduction
The removal of introns from nuclear mRNA precursors
occurs via a two-step transesterification mechanism involv-
ing both 5 and 3 splice site cleavages and exon ligation
(reviewed in Moore et al., 1993; Burge et al., 1999). The
splicing reaction is catalyzed by a large ribonucleoprotein
complex called the spliceosome. The spliceosome is com-
posed of four small ribonucleoprotein particles (U1, U2,
U5 and U4/U6 snRNPs) and numerous non-snRNP protein
splicing factors, which assemble on the pre-mRNA in an
ordered manner. The spliceosomal snRNPs contain five
small nuclear RNAs (U1, U2, U4, U5 and U6 snRNA) and
50 distinct proteins that are either common to all snRNPs
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or specific for a given particle (reviewed in Will and
Lu¨hrmann, 1997).
In the course of splicing, a network of both snRNA–
snRNA and snRNA–pre-mRNA interactions is formed
(Moore et al., 1993; Madhani and Guthrie, 1994; Nilsen,
1998; Staley and Guthrie, 1998). During the early stages of
spliceosome assembly, the U1 and U2 snRNPs recognize
and base pair with the 5 splice site and the branch site,
respectively, thereby generating the so-called pre-spliceo-
some, or complex A. Mature spliceosomes (i.e. complexes
B and C) are formed subsequently by the association of the
[U4/U6.U5] tri-snRNP particle with the pre-spliceosome.
Prior to the first step of splicing, the snRNAs, in particular
the U4 and U6 snRNAs of the [U4/U6·U5] tri-snRNP com-
plex, undergo dramatic conformational rearrangements,
which are thought to be driven by spliceosomal proteins
of the DEAD/DEXH-box family of ATP-dependent RNA
unwindases (Staley and Guthrie, 1998). Within the tri-
snRNP complex, the U4 and U6 snRNAs are base-paired
and form aphylogenetically highly conservedY-shapedU4/
U6 interaction domain, consisting of stem I and II separated
by the 5 stem–loop of U4 snRNA (Bringmann et al., 1984;
Hashimoto and Steitz, 1984; Rinke et al., 1985; Brow and
Guthrie, 1988; see Figure 2). After association of the tri-
snRNP with the pre-spliceosome, both stems of the U4/U6
interaction domain are disrupted. While the region of U6
snRNA constituting U4/U6 stem II forms a new intra-
molecular stem–loop, the region of U6 comprising stem I
basepairswithU2RNAto formpart of the catalytic centreof
the spliceosome (Datta and Weiner, 1991; Wu and Manley,
1991; Madhani and Guthrie, 1992; Sun and Manley, 1995).
Moreover, the conserved ACAGAG sequence of U6
snRNA base pairs with the 5 splice site of the pre-mRNA
(Fabrizio and Abelson, 1990; Sawa and Abelson, 1992;
Kandels-Lewis and Se´raphin, 1993; Lesser and Guthrie,
1993; Sontheimer and Steitz, 1993). In contrast to U6, U4
snRNA is released from the spliceosome or remains only
loosely attached to it (Lamond et al., 1988; Yean and Lin,
1991). It is thought that following the dissociation of
the post-spliceosomal complexes, the U4/U6 interaction
domain re-forms for a new round of splicing (Moore et al.,
1993). Thus,U4 snRNAhas beenproposed to act as anRNA
chaperone that deliversU6 to the spliceosomesequesteringa
catalytically active domain of U6 snRNA until the dissoci-
ation of the U4/U6 snRNA duplex activates this domain for
its function in splicing (Brow and Guthrie, 1989). Similar
structural rearrangements are also observed with the
recently discovered U4atac and U6atac snRNAs of the so-
called minor or U12-type spliceosome which are functional
analogues of U4 and U6. Both RNAs also form a Y-shaped
U4atac/U6atac interaction domain with the U4atac snRNA
5 stem–loop separating the two intermolecular helices I
and II (Tarn and Steitz, 1996). During minor spliceosome
assembly, the U4atac and U6atac snRNAs also dissociate,
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and U6atac snRNA engages in base pairing interactions
with the U12 snRNA (the functional analogue of the U2
snRNA) and the 5 splice site (Tarn and Steitz, 1996; Yu
and Steitz, 1997; Incorvaia and Padgett, 1998).
U4 snRNA is not as phylogenetically conserved as U6
snRNA, except for the structural organization of the U4/
U6 RNA interaction domain and the loop sequence of the
U4 snRNA 5 stem–loop (Brow and Guthrie, 1988; Guthrie
and Patterson, 1988). Sequences of the U4 snRNA required
for splicing have been investigated in vivo in yeast and
Xenopus oocytes, as well as in vitro in HeLa cell splicing
extracts. As expected, those regions of U4 snRNA known
to base pair with U6 were found to be important for U4/
U6 interaction and thus also for splicing. Moreover,
distinct regions in the central domain of U4 snRNA appear
to contribute to splicing, while the 3-terminal Sm domain
was shown to be dispensable for splicing in vitro (Vankan
et al., 1992; Wersig and Bindereif, 1992; and references
therein). Consistent with its high degree of evolutionary
conservation, the 5 stem–loop of U4 snRNA was demon-
strated to be essential for splicing in all systems investi-
gated. For example, deletion of the 5 stem–loop from the
Saccharomyces cerevisiae U4 snRNA gene SNR14 led to
cell inviability (Bordonne´ et al., 1990). Mutational ana-
lyses of U4 snRNA in Xenopus oocytes and in the HeLa
in vitro splicing system demonstrated that the 5 stem–
loop is essential for pre-mRNA splicing and spliceosome
assembly (Vankan et al., 1992; Wersig and Bindereif,
1992 and references therein). Since the U4 snRNA 5
stem–loop is dispensable for U4/U6 RNA base pairing
in vitro, it has been suggested that it functions in spliceo-
some assembly at a stage subsequent to U4/U6 snRNP
formation (Wersig and Bindereif, 1992). This idea is also
supported by the results obtained by mutational analysis
of the U4 snRNA 5 stem–loop in yeast (Bordonne´ et al.,
1990; Hu et al., 1995).
While the 5 stem–loop of U4 snRNA is clearly essential
for U4 snRNA function in pre-mRNA splicing, it is not
knownwhether its prime function is to interact directly with
otherRNAs in the spliceosome, or to recruit snRNPproteins
to the spliceosome. Consistent with the latter idea, the U4
snRNA 5 stem–loop is accessible to oligonucleotide-
directed RNase H cleavage only after phenolization of
snRNPs from both HeLa cell nuclear and yeast extracts
(Black and Steitz, 1986; Xu et al., 1990), suggesting that it
is associated with one or more proteins. Aside from the Sm
proteins, which are bound to the 3-terminal Sm site of
the U4 snRNA, relatively little is known about other U4
snRNA-associated proteins. The WD40 protein Prp4p of
theyeastS.cerevisiaewas thefirst protein shown toassociate
with U4/U6 snRNAs (Banroques and Abelson, 1989;
Peterson-Bjørn et al., 1989). Interestingly, antibodies
directed against Prp4p were shown to precipitate the 5
portion of U4 snRNA, including the conserved 5 stem–
loop (Bordonne´ et al., 1990; Xu et al., 1990). However,
direct interaction of Prp4p with U4 snRNA could not be
demonstrated. A second U4 snRNP candidate protein in
yeast is Prp3p, which is present in U4/U6 snRNPs and has
been shown to interact directly with Prp4p (Anthony et al.,
1997; Ayadi et al., 1998).
In the human 25S [U4/U6·U5] tri-snRNP, the 60kD and
90kD proteins have been identified as orthologues of the
yeast Prp4p and Prp3p proteins, respectively, and were
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also found to be associated specifically with the
U4/U6 snRNP particle (Horowitz et al., 1997; Lauber
et al., 1997). The U4/U6-specific 60kD and 90kD proteins
form a tight heteromeric complex with a 20kD cyclophilin,
which has also been identified as a U4/U6-specific protein
(Horowitz et al., 1997; Teigelkamp et al., 1998). It should
be noted that none of these proteins contains a canonical
RNA-binding motif such as a consensus RBD, a KH
domain, an RGG box or an arginine-rich motif (reviewed
in Burd and Dreyfuss, 1994; Cusack, 1999), nor has direct
binding of the 20/60/90kD heteromer to U4 or U6 snRNA
been reported so far.
Here we describe the molecular characterization of the
15.5kD protein of the HeLa 25S [U4/U6·U5] tri-snRNP.
The 15.5kD protein belongs to a group of tri-snRNP
proteins, with mol. wts of 15.5, 61 and 63/65 kDa,
which have not yet been assigned to one of the snRNPs
constituting the tri-snRNP complex (for a recent compil-
ation of human tri-snRNP proteins, seeWill and Lu¨hrmann,
1997). We show that the evolutionarily conserved 15.5kD
protein binds directly to the 5 stem–loop of human U4
snRNA as well as to U4atac snRNA in a specific manner.
The latter finding indicates that the 15.5kD protein is also
present in the [U4atac/U6atac·U5] tri-snRNP of the minor
U12-type spliceosome. The 15.5kD protein is a new
member of a family of RNP-associated proteins with a
novel RNA recognition motif. By mutagenesis experi-
ments, we have also characterized in detail the 15.5kD
protein-binding site which consists of a conserved purine-
rich structural element of the U4 snRNA 5 stem–loop.
Finally, we have investigated the functional importance
of the interaction between the 15.5kD protein and the U4
snRNA 5 stem–loop in pre-mRNA splicing. Our results
indicate that the 15.5kD and/or additional proteins associ-
ated with it play an important role in the late stage of
spliceosome assembly, after the [U4/U6·U5] tri-snRNP
has been integrated into the spliceosome, but prior to the
first catalytic step of splicing.
Results
Cloning of the HeLa 15.5kD tri-snRNP protein
The 15.5kD protein was isolated by fractionating proteins
from purified HeLa 25S [U4/U6·U5] tri-snRNPs as
described previously (Lauber et al., 1997). Microsequenc-
ing of the 15.5kD protein yielded two distinct peptide
sequences (see Materials and methods). A database search
with these peptide sequences identified several expressed
sequence tags (ESTs) from different human tissues, as
well as one human cDNA isolated from an embryonic
brain cDNA library, that encoded both peptide sequences
(Saito et al., 1996). Screening of a HeLa cDNA library
with the EST R72749 led to the isolation of a clone with
an open reading frame (ORF) encoding a putative protein
of 128 amino acids (Figure 1A). The identity of this
cDNA was verified by several criteria. First, both peptide
sequences obtained by microsequencing of the 15.5kD tri-
snRNP protein were present in the predicted amino acid
sequence of the cDNA-encoded protein. Furthermore,
antibodies raised against a recombinant fusion protein
containing GST and the cDNA-encoded protein specific-
ally recognized the endogenous 15.5kD protein on
immunoblots when proteins from gradient-purified 25S
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Fig. 1. Sequence alignment of the human 15.5kD protein with highly homologous proteins. (A) Human 15.5kD protein (AF155235) is aligned with
its orthologues from Caenorhabditis elegans (Q21568), Schizosaccharomyces pombe (AF087136), Saccharomyces cerevisiae (P39990), Drosophila
melanogaster (EST GH 03082) and Arabidopsis thaliana (sequence combined from EST T14197 and EST H76484). Identical residues are boxed in
black and conserved residues (grouped DE, KRH, LIVAMPYFW and TSQCN) are shaded grey. The amino acid positions are indicated by numbers.
(B) Human 15.5kD protein is aligned with human ribosomal protein L7a (P11518) and S12 (P47840), with Haloarcula marismortui ribosomal
protein HS6 (P12743), S.cerevisiae protein NHP2 (P32495) and ribosomal protein L32 from S.cerevisiae (P14120). Residues identical in at least four
out of six sequences are boxed in black and conserved residues are shaded grey. The sequence motif from position 35 to 90 of the human 15.5kD
protein is underlined with a black bar. Amino acids of the human 15.5kD protein exchanged by site-directed mutagenesis are indicated by a black
dot. The amino acid positions are indicated by numbers. Truncated sequences are marked with an asterisk at the point of truncation. Multiple
sequence alignments were done using the Clustal method (Higgins and Sharp, 1988) and optimized by visual inspection.
HeLa [U4/U6·U5] tri-snRNPs were used as a source
of antigen. Finally, in vitro translated 15.5kD protein
co-migrated on SDS–polyacrylamide gels with the
endogenous 15.5 kDa tri-snRNP protein (data not shown).
The 15.5kD tri-snRNP protein is evolutionarily
highly conserved and belongs to a family of
proteins with a novel putative RNA-binding
domain
A database search with the HeLa 15.5kD tri-snRNP protein
identified apparent orthologues in Caenorhabditis elegans,
S.cerevisiae, Schizosaccharomyces pombe, Drosophila
melanogaster and Arabidopsis thaliana which exhibited
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an extraordinarily high degree of homologywith the human
protein (71–77% identity, 83–89% similarity, Figure 1A).
Consistent with the idea that it is a 15.5kD orthologue,
the S.cerevisiae protein, termed Snu13p, is present in
purified yeast [U4/U6·U5] tri-snRNPs (Gottschalk et al.,
1999; Stevens and Abelson, 1999). The human 15.5kD
tri-snRNP protein shares significant homology with several
other proteins in the database which are clearly not 15.5kD
orthologues. These include the human ribosomal proteins
L7a and S12, the yeast ribosomal protein L32, the ribo-
somal protein HS6 from Haloarcula marismortui and the
yeast protein NHP2. NHP2 recently has been identified
as a common protein of all H/ACA box small nucleolar
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RNPs (Henras et al., 1998; Watkins et al., 1998). As
previously noted by Henras et al. (1998), all of these
proteins share a strongly conserved central region com-
prised of 56 amino acid residues (spanning positions 35–
90 of the human 15.5kD protein, Figure 1B). It should be
noted, however, that several short regions of homology
are also detected between the various members of this
family in the flanking N- and C-terminal regions
(Figure 1B). Consistent with the fact that all of these
proteins are components of RNP complexes, the
N-terminal 25 amino acid residues of the conserved central
region previously have been postulated to contain the
consensus sequence of a novel, putative RNA-binding
motif (Koonin et al., 1994).
The 15.5kD protein binds specifically to the 5
stem–loop of U4 snRNA
The observation that the 15.5kD protein belongs to a
family of proteins sharing a putative RNA-binding motif
(see above) prompted us to investigate whether it interacts
directly with one of the snRNAs of the [U4/U6·U5] tri-
snRNP. For this purpose, co-precipitation experiments
(GST pull-downs) were performed with purified recombin-
ant GST–15.5kD fusion protein. GST–15.5kD protein was
first coupled to glutathione–Sepharose and then incubated
with a mixture of snRNAs which were obtained by
phenolizing immunoaffinity-purified HeLa snRNPs at 0°C
to maintain U4/U6 base pairing (Bringmann et al., 1984).
As shown in Figure 2A, the U4/U6 snRNA duplex was
co-precipitated specifically with the GST–15.5kD protein,
but not with GST alone (upper panel, lanes 2 and 3). This
clearly demonstrates that the 15.5kD protein interacts
directly with one or both of these two snRNAs. In a
separate experiment, the snRNA mixture was incubated
for 1 min at 90°C (in order to dissociate the U4/U6
snRNA duplex) prior to addition of the GST–15.5.kD
protein. Under these conditions, exclusively U4 snRNA
was co-precipitated, demonstrating that the U4 snRNA is
sufficient for specific and stable complex formation with
the 15.5kD protein (Figure 2A, upper panel, lane 4).
A specific interaction of the 15.5kD protein with the
U4 snRNA was also observed with an alternative co-
immunoprecipitation approach. In this assay, we incubated
in vitro translated, 35S-labelled 15.5kD protein with m7G-
capped, in vitro transcribed U1, U2, U4, U5 or U6 snRNA.
The m7G-capped snRNAs were then precipitated with the
monoclonal anti-cap antibody H20. As monitored by SDS–
PAGE, the in vitro translated 15.5kD protein was co-
precipitated only with the U4 snRNA (Figure 2A, lower
panel).
In order to narrow down the RNA-binding site of the
15.5kD protein on the U4 snRNA, we performed hydroxyl
radical footprinting (Celander and Cech, 1990; Hu¨ttenhofer
and Noller, 1992; see Materials and methods) of the
in vitro reconstituted, binary U4 snRNA–15.5kD protein
complex. Primer extension analysis revealed that riboses
in two regions of the U4 snRNA backbone were clearly
protected from cleavage by hydroxyl radicals at increasing
concentrations of recombinant 15.5kD protein (FP1 and
FP2, Figure 2B). Intriguingly, both footprints map to the
phylogenetically conserved 5 stem–loop of U4 snRNA,
encompassing positions A29–G35 (FP2) and G43–C47
(FP1) (Figure 2C).
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Structural determinants of the U4 snRNA 5
stem–loop required for specific recognition by the
15.5kD protein
An initial clue to understand how the structural elements
in the U4 snRNA 5 stem–loop might contribute to the
specific recognition by the 15.5kD protein came from
phylogenetic sequence comparisons (see also Guthrie and
Patterson, 1988). Close inspection of the 5 stem–loop
sequences of U4 snRNAs currently available in the data-
base revealed that nucleotides U31, G32, A33, G43 and
A44 (nucleotide positions according to the sequence of
the human U4 snRNA) are 100% conserved in all U4
snRNAs, except for U31 in Trypanosoma brucei. Further-
more, positions A29 and A30 are always purines, excep-
tions being A29 in T.brucei and Physarum polycephalum.
Figure 3A shows the 5 stem–loop sequences from human,
yeast and Drosophila U4 snRNA as well as from human
U4atac snRNA as selected examples to illustrate this
phylogenetic conservation. The nucleotide corresponding
to position 30 in human U4 snRNA is either an A or G.
In addition, two base pairs potentially form between
nucleotides G34 and C42, and G35 and C41, respectively.
The potential G35–C41 base pair is phylogenetically
conserved between the human, yeast and Drosophila loop
sequences and is inverted to a C-G base pair in the human
U4atac snRNA loop (Figure 3A). The presence of such a
compensatory base change provides strong evidence for a
base pair (reviewed in Michel and Costa, 1998). Similarly,
the existence of the neighbouring base pair (G34–C42) is
also supported by compensatory base mutations. That is,
the canonical G–C base pair is replaced by a G·U base
pair in human U4atac snRNA and by an A–U base pair
in Drosophila U4 snRNA (Figure 3A). In all known U4
snRNA sequences, except in T.brucei, both base pairs
show 100% covariation (data not shown). The nature of
the remaining loop nucleotides (positions U36–U40 of the
human U4 snRNA) varies significantly among the different
U4 snRNAs with no apparent conservation in primary
sequence. Finally, while the stem as such is conserved,
its precise sequence is not, except for the polarity of the
G–C base pair closing the loop, which is conserved in all
U4 snRNA sequences (Figure 3A; data not shown).
To investigate whether the 5 stem–loop is sufficient
for binding the 15.5kD protein, we used a chemically
synthesized mini stem–loop RNA oligonucleotide corres-
ponding to nucleotides 26–47 of the human U4 snRNA
(henceforth termed human U4SL) which contained an
additional G–C base pair to stabilize the short stem. The
interaction of recombinant 15.5kD protein with this RNA
oligonucleotide was then analysed by electrophoretic
mobility shift assays (EMSAs). As shown in lane 1 of
Figure 3B, the 15.5kD protein effectively forms a complex
with the human U4SL, demonstrating that the 5 stem–
loop of U4 snRNA is sufficient for 15.5kD protein
binding. Efficient binding of the U4 snRNA 5 stem–loop
oligonucleotide was likewise observed in a pull-down
experiment carried out with a GST–15.5kD fusion protein
under the same conditions used for U4 snRNA–15.5kD
protein complex formation as shown in Figure 2A (data
not shown).
The importance of the nucleotides at positions 29–33,
43 and 44 of the human U4 snRNA 5 stem–loop for
complex formation with the 15.5kD protein was next
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Fig. 2. The 15.5kD protein binds directly to the 5 stem–loop of U4 snRNA. (A) Upper panel: U4 snRNA is co-precipitated specifically with
GST–15.5kD in a GST pull-down assay. UsnRNAs were co-precipitated after incubation with immunoaffinity-purified HeLa snRNPs by monoclonal
antibody Y12 (Lerner et al., 1981) coupled to protein A–Sepharose (lane 1). Control precipitation of a mixture of native UsnRNAs with glutathione–
Sepharose-coupled GST (lane 2). Co-precipitation of UsnRNAs after incubation of a mixture of native (lane 3) or heat-denatured (lane 4) UsnRNAs
with glutathione–Sepharose-coupled GST–15.5kD. Bound UsnRNAs were recovered by phenol extraction and ethanol precipitation, 3-end-labelled
and separated on a denaturing 10% polyacrylamide–7 M urea gel. The identity of the precipitated UsnRNAs was verified by Northern blot analysis
(data not shown). Lower panel: in vitro translated, 35S-labelled 15.5kD protein was co-immunoprecipitated specifically with U4 snRNA by protein
A–Sepharose-coupled monoclonal antibody H20 as monitored by SDS–PAGE. Lane 1: 10% input of 35S-labelled 15.5kD protein. Co-immuno-
precipitations were performed without RNA (lane 2) or in the presence of the indicated, in vitro transcribed, m7G-capped UsnRNAs (lanes 3–7).
(B) Hydroxyl radical footprint of the U4 snRNA–15.5kD protein complex as analysed by primer extension. Riboses protected from cleavage at
increasing 15.5kD protein concentration (0.3–134 pmol) are marked with black bars and designated FP1 and FP2. Since hydroxyl radical attack of a
nucleotide results in its complete removal from the RNA chain, reverse transcriptase will stop one nucleotide before the site of attack. The first and
the last lanes (labelled ‘–’) contain unmodified U4 snRNA to control for spontaneous stops by the reverse transcriptase. C, U, A and G refer to
dideoxysequencing reactions and correspond to the sequence of endogenous HeLa U4 snRNA. 0 indicates a control primer extension with
unmodified U4 snRNA where no ddNTPs were added to the reaction. The position of every tenth nucleotide of the U4 snRNA is indicated on the
left. (C) Secondary structure model of the human U4/U6 snRNA duplex according to Bringmann et al. (1984) and Brow and Guthrie (1988). The
positions of the footprints, FP1 and FP2, are indicated by black dots. Large dots indicate strong and smaller dots indicate weaker protection of
riboses from hydroxyl radicals. The nucleotide positions of the U4 and U6 snRNAs are indicated by numbers.
investigated with a battery of chemically synthesized
U4SL mutant RNA constructs. From the combined results,
we can classify the seven nucleotides into at least two
groups as summarized in Figure 3C. At positions 29 and
30, the requirement for a particular nucleotide is less
stringent, in that the adenosines can be replaced individu-
ally by guanosines without any loss of 15.5kD protein-
binding activity (Figure 3B, lanes 3 and 4). If both
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positions contain guanosines, protein binding is reduced
slightly but reproducibly (lane 5). In contrast, if the
two adenosines are replaced simultaneously by cytidines,
protein-binding activity is lost (data not shown). Further-
more, deletion of one adenosine residue has a deleterious
effect on the capability of the resulting mutant to interact
with the 15.5kD protein (lane 7). These data indicate a
preference for purines at positions 29 and 30 of the loop.
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In good agreement with their phylogenetic conservation
(see above), the identity of nucleotides U31, G32, A33,
G43 and A44 is crucial for protein-binding activity in vitro
as analysed by bandshift assays. A summary of the results
obtained with all the U4SL mutants tested is shown in
Figure 3C and selected examples of the mobility shift
experiments are shown in Figure 3B (lanes 6, 9, 10 and
11). In all cases, both transitions and transversions of
these nucleotides led to the complete loss of binding
activity. Finally, we show that the polarity of the base
pair closing the loop is not crucial for recognition by the
15.5kD protein: a U4SL mutant with an inverted base pair
exhibits only a slightly lower degree of binding activity
(Figure 3B, lane 8).
In support of the RNA structural requirements for
recognition by the 15.5kD protein described so far, chemic-
ally synthesized mini stem–loops of the human U4atac
and yeast U4 snRNAs also bound the 15.5kD protein
(Figure 3B, lanes 12 and 13; see also Figure 3A for
sequence comparison). Interestingly, as shown by competi-
tion assays (Figure 3D), the 15.5kD protein bound to the
U4atac stem–loop oligonucleotide even more efficiently
than to the human U4SL oligonucleotide. An ~5-fold
higher concentration of U4SL, as compared with U4atac
oligonucleotide, was required to completely inhibit binding
of the 15.5kD protein to U4 snRNA (Figure 3D, compare
lanes 3–6 with 11–14). The inhibition of U4 snRNA–
15.5kD protein complex formation by both 5 stem–loop
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oligonucleotides was specific, since equivalent concentra-
tions of a mutant U4SL oligonucleotide did not compete
for 15.5kD protein binding (Figure 3D, lanes 7–10).
The interaction of the 15.5kD protein with the U4atac
SL was significant for two reasons. First, this indicates
that the 15.5kD protein is most likely to be shared by the
major and minor tri-snRNP particle. Second, the fact that
the putative G34–C42 and G35–C41 base pairs in human
U4 snRNA are changed to G39·U47 and C40–G46 in
human U4atac snRNA without loss of 15.5kD protein
binding suggests that the base pair formation between
these nucleotides and not their identity may be of prime
importance for proper protein–RNA complex formation
in vitro. Consistent with this idea, replacement of the
putative G39·U47 base pair in the U4atac snRNA 5 stem–
loop with a U39–A47 base pair had no effect on 15.5kD
protein binding (Figure 3B, lane 16). Interestingly, a single
point mutation changing U47 to A completely abolished
complex formation, while mutation of G39 to U still
allowed efficient 15.5kD protein binding (lanes 15 and
18, respectively). These results indicate that non-canonical
G·U and U·U, but not G·A base pairs at this position of
the U4atac 5 stem–loop are compatible with recognition
by the 15.5kD protein. Finally, 15.5kD protein binding
was completely lost when the putative C40–G46 base pair
was disrupted by single base mutations such as C40A
(Figure 3B, lane 17), experimentally supporting the import-
ance of this base pair in U4atac SL for protein binding.
Fig. 3. The 15.5kD protein recognizes phylogenetically conserved
nucleotides of the U4 snRNA 5 stem–loop. (A) 5 Stem–loop
sequences of human, S.cerevisiae and D.melanogaster (D00043) U4
snRNA and human U4atac snRNA. Nucleotide positions are indicated
by numbers. Phylogenetically conserved nucleotides are boxed, and
potential base pairs are indicated by dashed lines. (B) EMSA of the
interaction between the 15.5kD protein and U4 snRNA 5 stem–loop
oligonucleotides. Recombinant 15.5kD protein was reconstituted
in vitro with 5-end-labelled RNA oligonucleotides and the protein–
RNA complexes were resolved on a 10% native polyacrylamide gel.
The position of the protein–RNA complex is indicated on the left.
Lanes 1–11: bandshifts of wild-type and mutant RNA oligonucleotides
corresponding to positions 26–47 of the human U4 snRNA 5 stem–
loop; the triple mutant RNA oligonucleotide shown in lane 2 contains
the following substitutions: A30C, U31G, G32U (according to Vankan
et al., 1992). Lane 12: RNA oligonucleotide corresponding to
positions 31–52 of human U4atac snRNA. Lane 13: RNA
oligonucleotide corresponding to positions 26–48 of S.cerevisiae U4
snRNA. Lanes 14–18: bandshifts of mutant RNA oligonucleotides
corresponding to position 30–51 of the human U4atac snRNA 5
stem–loop. All RNA oligonucleotides contain an additional G–C base
pair at the top of the stem. (C) Substitution and deletion mutants of
the human U4 snRNA 5 stem–loop oligonucleotide (human U4SL).
The efficiency of 15.5kD protein binding for the mutant RNA
oligonucleotides, as determined by the bandshift analysis, is indicated
by ‘’ and ‘–’. Essential nucleotides are boxed in black and
nucleotides involved in potential base pairing are shaded grey. The
G–C base pair which is not found in the human wild-type U4 snRNA
sequence is shown in brackets. (D) The 5 stem–loop suffices to
compete for the 15.5kD protein–U4 snRNA interaction. Inhibition of
the U4 snRNA–15.5kD protein complex formation was assayed by
EMSA (see Materials and methods for details). The competitors used
were human U4SL (lanes 3–6), a triple mutant U4SL (A30C, U31G,
G32U, see above; lanes 7–10) and U4atac SL (lanes 11–14). No
competition was observed at equivalent concentrations of mutant
U4SL. Lane 1: U4 snRNA without 15.5kD protein. Lane 2: U4
snRNA incubated with 15.5kD protein at a final protein concentration
of 1 μM. The competitor concentrations assayed were 5 (lanes 3,
7 and 11), 50 (lanes 4, 8 and 12), 100 (lanes 5, 9 and 13) and 250
(6, 10 and 14) pmol. The position of the U4 snRNA–15.5kD protein
complex and free U4 snRNA is indicated on the left.
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Fig. 4. Characterization of the 15.5kD RNA recognition motif.
(A) Binding of in vitro translated, 35S-labelled wild-type and mutant
15.5kD proteins to human U4 snRNA. The protein–RNA complex was
reconstituted in vitro and co-immunoprecipitation of wild-type and
mutant 15.5kD protein with protein A–Sepharose-coupled monoclonal
antibody H20 was monitored by SDS–PAGE. Input: 10% input of
in vitro translated 15.5kD protein. IP: co-immunoprecipitated 15.5kD
protein bound to U4 snRNA. (B) Proteolytic digestion of the in vitro
reconstituted protein–RNA complex. Free recombinant 15.5kD protein
and 15.5kD protein bound to the U4atac snRNA 5 stem–loop
oligonucleotide (U4atac SL) were incubated with endoproteases Glu-C
(left panel) and Lys-C (right panel) for 0 min, 1 min, 30 min, 2 h or
16 h. Protease digestion products subsequently were separated by
SDS–PAGE and visualized by silver staining. The position of the
full-length 15.5kD protein is indicated on the right by an arrowhead.
The negatively stained double band at 31kD in the right panel is the
enzyme Lys-C.
Taken together, our results indicate that the 15.5kD protein-
binding site consists of an asymmetric internal purine-rich
loop flanked by the long stem of the 5 stem–loop and a
short stem of two base pairs.
The central region of the 15.5kD protein is
essential but not sufficient for U4 snRNA binding
A conspicuous feature of the 15.5kD protein is a 56 amino
acid central region which exhibits significant homology
with several other proteins that are all components of
RNP complexes (Figure 1B, see also Henras et al., 1998).
Having identified the 15.5kD protein as a novel U4
snRNA-binding protein, we were interested to learn more
about the contribution of the central and also the flanking
regions of the 15.5kD protein to its RNA-binding activity.
To this end, three highly conserved amino acids within
the central region of the protein were mutated (see
Figure 1B) and the ability of the in vitro translated, 35S-
labelled mutant proteins to bind U4 snRNA was assayed
by co-immunoprecipitation analyses with an anti-cap anti-
body. As shown in Figure 4A, mutation of Gly38 to
lysine (G38K), as well as the exchange of Ala57 with
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phenylalanine (A57F), completely abolished binding of
the 15.5kD protein to U4 snRNA (lanes 4 and 6). This
demonstrates that both amino acids, which are 100%
conserved among those proteins containing this central
homologous region, are essential for 15.5kD RNA-binding
activity. Mutation of Tyr80 to alanine (Y80A) strongly
reduced U4 snRNA binding (by ~50%) but did not abolish
it. Thus, an aromatic amino acid residue at this position
is clearly favourable but not essential, consistent with the
fact that the human ribosomal protein S12 contains a
leucine residue at the equivalent position (see Figure 1B).
To investigate the possible contribution of the C-terminal
region of the 15.5kD protein to RNA-binding activity, we
constructed a deletion mutant of the protein lacking the
C-terminal 33 amino acids. As shown in Figure 4A,
deletion of this region completely abolished binding to
the U4 snRNA (lane 10), indicating that C-terminal
residues are also essential for binding activity.
These data further suggest that the evolutionarily con-
served central region of the 15.5kD protein is necessary,
but not sufficient for RNA binding. This idea is also
consistent with the results obtained from partial proteolytic
digestion of the protein in the absence or presence of the
U4atac SL RNA oligonucleotide. As shown in Figure 4B,
binding of U4atac SL to the 15.5kD protein has a striking
effect on the stability of the protein towards proteases.
While the free protein was hydrolysed rapidly by either
Glu-C or Lys-C proteases (70–80% after 2 h and 100%
after 16 h, lanes 2–6 of both panels), the RNA-bound
protein was completely protected from protease cleavage
by Lys-C even after incubating for 16 h (lanes 7–10, right
panel). Similar results were obtained with trypsin and
chymotrypsin (data not shown) and Glu-C, except that the
15.5kD protein was cleaved by Glu-C and chymotrypsin
close to the C- or N-terminus even when it was complexed
with the U4atac SL RNA oligonucleotide (Figure 4B, left
panel and data not shown). Importantly, however, the
slightly shorter fragment remained stable over the entire
16 h incubation period (lanes 7–10). The dramatic protec-
tion of the 15.5kD protein against protease hydrolysis was
strictly dependent on U4 snRNA SL–15.5kD protein
complex formation. In the presence of a mutant U4SL,
inactive in 15.5kD protein binding as determined by a gel
mobility shift assay (see Figure 3B, lane 2), protection of
the 15.5kD protein from rapid protease digestion was not
observed (not shown). Taken together, our combined
results suggest that the 15.5kD protein in its entirety may
be required for specific interaction with the U4 snRNA
5 stem–loop.
The U4 snRNA stem–loop oligonucleotide inhibits
the first step of pre-mRNA splicing
Previous mutagenesis analyses in vivo and in vitro demon-
strated that the 5 stem–loop of U4 snRNA is essential
for pre-mRNA splicing (see Introduction). However, it
was not clear from these studies whether or not the
observed deleterious effects were due to the disruption of
the interaction of U4 snRNA 5 stem–loop-binding pro-
teins. We were therefore interested in investigating the
role of the 15.5kD protein in pre-mRNA splicing in vitro
more directly. For this purpose, we added the human,
wild-type U4SL RNA oligonucleotide to an in vitro
pre-mRNA splicing reaction, reasoning that U4SL might
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Fig. 5. An excess of wild-type U4 and U4atac SL inhibits pre-mRNA
splicing in vitro. (A) Standard in vitro splicing assays were performed
with HeLa cell nuclear extract in the presence of increasing amounts
of wild-type (human U4SL, lanes 3–7), mutant (U4SL triple mutant,
lanes 9–13) and U4atac SL (lanes 15–19) 5 stem–loop oligo-
nucleotides (20, 40, 80, 160 and 240 pmol, respectively). Lane 1:
standard splicing assay performed at 0°C. Lanes 2 and 8: standard
splicing assays without RNA oligonucleotide. (B) The inhibitory effect
of human U4SL can be reversed by the addition of recombinant
15.5kD protein. Lane 1: standard splicing assay. Lane 2: standard
splicing assay in the presence of human U4SL (225 pmol). Lanes 3–6:
standard splicing assays in the presence of human U4SL (225 pmol)
and increasing amounts of recombinant 15.5kD protein (100, 225, 450
and 700 pmol). The reaction mixtures were incubated at 30°C for
60 min. The RNA subsequently was recovered by phenol extraction
and ethanol precipitation and separated on a denaturing 14%
polyacrylamide–8 M urea gel. The positions of the pre-mRNA,
splicing intermediates and product are indicated on the right. From top
to bottom: lariat–exon 2, excised intron–lariat, pre-mRNA, spliced
mRNA, exon 1.
sequester the 15.5kD protein at some stage during the
assembly of the [U4/U6·U5] tri-snRNP into mature
spliceosomes. Indeed, human U4SL effectively inhibited
pre-mRNA splicing, blocking the first catalytic step of the
reaction (Figure 5A, lanes 3–7). In contrast, when a mutant
U4SL oligonucleotide that does not bind to the 15.5kD
protein (see Figure 3B, lane 2, triple mutant A30C, U31G,
G34U) was added to the in vitro pre-mRNA splicing
reaction, only minor effects on splicing were observed at
the highest concentration of oligonucleotide (Figure 5A,
lanes 9–13). Similar results were obtained with other
U4SL mutants that were shown not to bind the 15.5kD
protein (data not shown). Interestingly, U4atac SL inhibited
pre-mRNA splicing even more efficiently than U4SL
(Figure 5A, compare lanes 5–7 with lanes 17–19). Since
U4atac SL binds the 15.5kD protein more efficiently than
U4SL (see Figure 3D), these results demonstrate that the
ability of the U4 snRNA 5 stem–loop to inhibit pre-
mRNA splicing correlates well with its 15.5kD protein-
binding activity. To determine whether the human U4SL
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Fig. 6. Wild-type U4SL inhibits the formation of spliceosomal
complex C, but not B. Standard splicing reactions were performed at
30°C for 0, 5, 10 and 20 min in the absence of exogenously added
RNA oligonucleotide (lanes 1–4) or in the presence of either 250 pmol
of wild-type (human U4SL, lanes 5–8) or mutant RNA oligonucleotide
(U4SL triple mutant, lanes 9–12). The spliceosomal complexes were
resolved by native gel electrophoresis and visualized by
autoradiography.
RNA oligonucleotide inhibits pre-mRNA splicing by
specifically sequestering the 15.5kD protein, we investi-
gated the effect of wild-type U4SL in the presence
of increasing amounts of recombinant 15.5kD protein.
Significantly, the 15.5kD protein was able to restore pre-
mRNA splicing efficiently (Figure 5B). Addition of the
15.5kD protein to a standard splicing reaction in the
absence of U4SL oligonucleotide did not affect the effici-
ency of the splicing reaction (data not shown). Taken
together, our results indicate that the 15.5kD protein plays
an important role in the splicing process.
The U4 snRNA stem–loop oligonucleotide inhibits
pre-mRNA splicing after spliceosomal complex B
formation
To determine at which step in the spliceosomal assembly
pathway the human U4SL oligonucleotide exerted its
inhibitory effect, we analysed the formation of spliceo-
somal complexes by native gel electrophoresis. The
kinetics of formation of pre-mRNA complexes containing
hnRNP proteins (H complex), U1 and U2 snRNPs (A
complex), U2 snRNP and the tri-snRNP (B complex) and
those that have undergone the first catalytic step of splicing
(C complex) is shown in Figure 6 (lanes 1–4). Interestingly,
addition of wild-type U4SL, at a concentration which
inhibits pre-mRNA splicing by ~90% (see Figure 5A, lane
7), leads to the inhibition of C complex formation and an
accumulation of B complexes (Figure 6, lanes 7 and 8).
In contrast, mutant U4SL oligonucleotides (i.e. U4SL
triple mutant, Figure 6, lanes 9–12), which are incapable
of binding the 15.5kD protein, did not inhibit C complex
formation, nor did they lead to an accumulation of complex
B. This finding is consistent with the observed failure of
this U4SL mutant to inhibit pre-mRNA splicing
(Figure 5A, lanes 9–13).
The observed accumulation of spliceosomal B com-
plexes in the presence of U4SL (Figure 6) indicated that
the oligonucleotide did not interfere with the early steps
of [U4/U6·U5] tri-snRNP integration into spliceosomes.
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In agreement with this idea, incubation of purified [U4/
U6·U5] tri-snRNPs with equivalent concentrations of
U4SL oligonucleotide, as used in Figure 6, did not lead
to dissociation of the tri-snRNP into U4/U6 and U5
snRNPs as investigated by co-immunoprecipitation experi-
ments with snRNP-specific antibodies (data not shown).
Our results therefore suggest that the 15.5kD protein
may become accessible to sequestration by the U4SL
oligonucleotide only after the [U4/U6·U5] tri-snRNP has
been integrated into the spliceosome, but prior to the first
catalytic step of the pre-mRNA splicing reaction.
This idea is supported further by the results of immuno-
precipitation experiments carried out with a rabbit antibody
specific for the recombinant 15.5kD protein (see above).
Anti-15.5kD antibodies efficiently precipitated native
15.5kD protein prepared by in vitro translation (Figure 7A,
compare lanes 2 and 3). However, the antibody failed to
precipitate isolated [U4/U6·U5] tri-snRNPs above the
background values observed with the non-immune serum
control (Figure 7B, lanes 2 and 3), suggesting that the
15.5kD protein probably interacts with other components
of the tri-snRNP, rendering it inaccessible to the antibody.
We next investigated whether the 15.5kD protein
becomes accessible after the [U4/U6·U5] tri-snRNP has
been integrated into spliceosomes. For this purpose, we
have analysed the kinetics of the pre-mRNA splicing
reaction by denaturing polyacrylamide gel electrophoresis
(Figure 7C, lanes 1–7). At each time point, a second
aliquot of the splicing reaction was subjected to immuno-
precipitation with anti-15.5kD antibodies and the
precipitated radiolabelled pre-mRNA molecules were ana-
lysed (Figure 7C, lanes 8–14). Interestingly, significant
co-precipitation of pre-mRNA by the 15.5kD-specific
antibody was first observed after 10 min of incubation
(Figure 7C, lane 11). At this time point, efficient spliceo-
somal B complex formation has already occurred (compare
Figure 6), but not catalysis of the pre-mRNA splicing
reaction (Figure 7C, lane 4). Non-immune serum, on the
other hand, did not precipitate any pre-mRNA above
background values at any time point (data not shown).
Also, at later time points (20 min), when pre-mRNA
splicing occurs, predominantly unspliced pre-mRNA was
co-precipitated by the anti-15.5kD antibody (Figure 7C,
lanes 5 and 12). In summary, these results suggest that
after its integration into the spliceosome, but prior to the
first step of splicing, the tri-snRNP complex undergoes a
conformational change such that the 15.5kD protein
becomes accessible to reaction with antibodies. Similarily,
it is also reasonable to assume that the 15.5kD protein
may become accessible to sequestration by U4SL during
this stage of spliceosome assembly, thus leading to the
inhibition of pre-mRNA splicing (Figures 5 and 6).
Discussion
The 15.5kD tri-snRNP protein binds to a conserved
structural element of the U4 snRNA
5 stem–loop
The 5 stem–loop is one of the most conserved regions
of U4 snRNA (Guthrie and Patterson, 1988) and plays
an essential role in the function of U4 snRNA during
pre-mRNA splicing (see Introduction). It previously had
been shown that the loop region of the U4 snRNA 5
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Fig. 7. Differential accessibility of the 15.5kD protein towards
anti-15.5kD antibodies in purified [U4/U6·U5] tri-snRNP and
spliceosomal B complexes. (A) Anti-15.5kD antibodies react
specifically with the native 15.5kD protein prepared by translation
in vitro. 35S-labelled translates of the 15.5kD protein were precipitated
with non-immune serum (lane 2) or 15.5kD-specific antiserum (lane 3).
In vitro translated 15.5kD protein shown in lane 1 is equivalent to
10% of the amount used in the immunoprecipitation assays. Proteins
were fractionated on a 13% SDS–polyacrylamide gel and visualized
by fluorography. (B) Anti-15.5kD antibodies do not precipitate purified
HeLa [U4/U6·U5] tri-snRNPs. [U4/U6·U5] tri-snRNPs purified from
HeLa nuclear extracts by immunoaffinity chromatography and glycerol
gradient centrifugation were used for immunoprecipitation
experiments. Immunoprecipitation was performed at 150 mM NaCl
with the monoclonal antibody Y12 (Lerner et al., 1981) to monitor the
total amount of tri-snRNPs present (lane 1), with non-immune serum
as a negative control (lane 2) and with antiserum specific for the
15.5kD protein (lane 3). The identity of the precipitated snRNAs is
indicated on the left. Note that U6 snRNA is labelled inefficiently at
the 3 end with pCp. (C) Anti-15.5kD antibodies precipitate
spliceosomal B complexes. Standard in vitro splicing assays were
performed as described in Materials and methods. Reaction mixtures
were incubated for the indicated times, and RNA subsequently was
recovered and separated on a 14% polyacrylamide–8 M urea gel
(lanes 1–7). At each time point, an aliquot of the total reaction was
subjected to immunoprecipitation with anti-15.5kD antibodies, and
co-precipitated RNA (lanes 8–14) was analysed in parallel with the
control splicing reactions. The positions of the pre-mRNA, splicing
intermediates and products are indicated on the right. From top to
bottom: lariat–exon 2, excised intron–lariat, pre-mRNA, spliced
mRNA, exon 1.
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Fig. 8. RNA secondary structures of the 15.5kD and L32 protein-
binding sites. The proposed secondary structure of the human U4
snRNA 5 stem–loop is shown on the left and the structure of the L32
RNA-binding site according to Li et al. (1995) is shown on the right.
Nucleotides conserved in both structures are boxed in black and
nucleotide positions are indicated by numbers.
stem–loop is accessible to oligonucleotide-directed RNase
H hydrolysis in the free U4 snRNA, but not in HeLa cell
nuclear or yeast cellular extracts (Black and Steitz, 1986;
Xu et al., 1990), suggesting that this part of U4 might be
tightly associated with proteins in these extracts. Here we
demonstrate that the 15.5kD protein of the human [U4/
U6·U5] tri-snRNP binds directly and specifically to the
U4 snRNA 5 stem–loop. The 5 stem–loop appears to be
the sole binding site of the 15.5kD protein on the U4
snRNA, as indicated by our observations that the recom-
binant protein formed a binary RNA–protein complex
with similar efficiency irrespective of whether the U4/U6
snRNA hybrid, free U4 snRNA or a chemically synthe-
sized RNA oligonucleotide comprising exclusively the 5
stem–loop sequence was used as RNA substrate (Figures 2
and 3). The results of these binding studies are consistent
with those of our hydroxyl radical footprinting experiments
which showed that in the U4 snRNA–15.5kD protein
complex only nucleotides of the 5 stem–loop were pro-
tected against hydroxyl radical cleavage (Figure 2). Inter-
estingly, the free U4 snRNA can also be folded into a
conserved secondary structure in which the 5 stem–loop
structure remains unchanged (Myslinski and Branlant,
1991). This raises the possibility that the interaction
between the 15.5kD protein and the 5 stem–loop of U4
snRNA must not necessarily be disrupted during the
unwinding of the U4/U6 snRNA duplex which is required
for activation of the spliceosome (see Introduction and
below).
With the goal of identifying loop sequence elements
and secondary structural features important for 15.5kD
protein binding, we have carried out an extensive muta-
tional analysis of the 5 stem–loop. The results of these
experiments, combined with phylogenetic sequence com-
parisons, indicate that the 15.5kD protein-binding site
consists of an internal asymmetric loop which is closed
by the long stem of the 5 stem–loop and a short stem
(see Figure 8). The short stem is comprised of two
base pairs formed between nucleotides 34/42 and 35/41
(numbering according to the human U4 snRNA sequence).
The requirement for the short stem for 15.5kD protein
binding was verified experimentally by mutational analysis
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of the corresponding nucleotides in the U4atac snRNA
stem–loop (Figure 3). In addition, the presence of the two
base pairs forming the short stem is supported by the fact
that compensatory base changes have occurred during
evolution at the corresponding positions of the 5 stem–
loop in U4 snRNAs of diverse species (Guthrie and
Patterson, 1988; see Figure 3A). Our results further
indicate that the stem as such, but not the nature of the
base pairs, is of prime importance for 15.5kD protein
binding. Likewise, the identity of the base pairs in the
long 5 stem did not appear to be important for complex
formation with the 15.5kD protein (Figure 3).
In contrast to the situation with the two stems, the
15.5kD protein-binding site is strictly dependent on the
precise sequence of the internal loop, i.e. five out of seven
positions, namely U31, G32 and A33 on the 5 side, and
G43 and A44 on the 3 side of the internal loop, cannot
be changed or deleted without abolishing protein-binding
activity (Figure 3B). Consistent with their central role in
providing a protein-binding site, these nucleotides are
evolutionarily extremely conserved among U4 snRNAs
of different species and are also conserved between the
human U4 and U4atac snRNAs (Figure 3A, Guthrie and
Patterson, 1988). The sequence requirement at positions
29 and 30 on the 5 side of the internal loop is less
stringent, but purines, as opposed to pyrimidines, are
required for efficient 15.5kD protein binding (Figure 3).
Deletion of one or both adenosine residues at positions
29 and 30 is deleterious for protein binding (Figure 3B
and data not shown), demonstrating that the 5 side of the
internal loop requires five nucleotides for maintaining an
active protein-binding site.
Due to the high conservation of individual bases in the
internal loop, it is difficult to distinguish which nucleotides
are important for direct protein recognition and which for
maintaining an RNA structure active in 15.5kD protein
binding. Similarily, it is difficult to verify possible base
pairing interactions within the loop. For example, a second-
ary structural model has been proposed for the free, human
U4 snRNA 5 stem–loop, which would involve a non-
canonical base pairing interaction between U31 and G43
(Sahasrabudhe et al., 1997). For this reason, we tested an
RNAmutant which contained a compensatory base change
at these positions (U31G and G43U). This RNA stem–
loop oligonucleotide, which potentially could form an
inverted G·U base pair, did not possess any protein-
binding activity (data not shown). Taken together, these
results strongly support the idea that the identity of the
nucleotides at positions 31–33, 43 and 44 is crucial for
maintaining a three-dimensional structure that is recog-
nized specifically by the 15.5kD protein. Alternatively, it
is also possible that the loop may adopt different structures
in the naked as compared with the protein-bound state.
Clearly, the answer to these questions will have to await
the determination of the three-dimensional structure of
this RNA–protein complex by X-ray crystallography and/
or NMR studies.
Similarities between the 15.5kD protein and the
yeast L32 ribosomal protein-binding sites on U4
snRNA and L32 pre-mRNA
The ribosomal protein L32 of S.cerevisiae binds to the
5 end of the L32 transcript thereby autoregulating the
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processing and translation of its own mRNA (Eng and
Warner, 1991; Vilardell and Warner, 1997). The binding
site for L32 consists of an asymmetric (52), purine-rich
internal loop closed by two stems (Li et al., 1995; White
and Li, 1996; Li and White, 1997). As the 15.5kD protein
and the L32 protein share a homologous 56 amino acid
central region (see Figure 1 and below), it is interesting
to note that the cognate RNA-binding sites of the two
proteins exhibit striking similarities (Figure 8). Signific-
antly, several of the nucleotides in the U4 snRNA internal
loop identified in this study to be essential for 15.5kD
protein binding, in particular the two GA dinucleotides
(boxed in black in Figure 8), are also conserved in the
L32-binding site and cannot be replaced by any other
nucleotide (see Li and White, 1997, and references
therein). Moreover, both RNAs contain purines at positions
29/30 and 55/56, respectively (Figure 8). A major differ-
ence between the two RNA-binding sites, however, is that
U31 of U4 snRNA, which was shown to be essential for
efficient binding of human 15.5kD protein, is replaced by
an adenosine residue (A57) in the L32 RNA (Figure 7).
An additional distinguishing feature is the non-canonical
G·U base pair that closes the internal loop of the L32 RNA
and which is critical for strong L32 protein binding (Li
and White, 1996). Despite these differences, it is tempting
to suggest that the two RNA-binding sites may fold into
three-dimensional conformations whose key features are
similar in both RNAs. Yet, by varying a few nucleotides
that are probably not important for maintaining the crucial
framework of the three-dimensional fold, protein binding
specificity is brought about. It will be interesting to see
whether other members of the protein family sharing the
56 amino acid homology region (see Figure 1 and below)
also bind to internal stem–loop stem structures which
exhibit sequence similarities with the 15.5kD protein and
L32 protein-binding sites.
The 15.5kD protein belongs to a family of proteins
with a novel RNA recognition motif
The human 15.5kD protein is evolutionarily highly con-
served and orthologues were identified in plants, insects,
nematodes and yeasts. In view of the phylogenetic conser-
vation of both the 15.5kD protein and its binding site on
U4 snRNA (see Figures 1A and 3A), it is very likely that
the orthologues of the human 15.5kD protein will also
bind U4 RNA in their respective organisms. Consistent
with this idea is the finding that the 15.5kD orthologue
from S.cerevisiae, termed Snu13p, is present in purified
yeast [U4/U6·U5] tri-snRNPs (Gottschalk et al., 1999;
Stevens and Abelson, 1999).
The human 15.5kD protein (as well as its orthologues)
is rich in hydrophobic amino acids (53 out of 128
positions), particularly in its central region where several
blocks of hydrophobic amino acids are conserved
(Figure 1A). Based on sequence comparisons, the 15.5kD
protein does not exhibit obvious structural similarities with
members of well-established families of RNA-binding
proteins (see Introduction). However, it shares the homo-
logous central region of 56 amino acids with several
proteins from a variety of species which have one feature
in common: they are all associated with RNP particles.
The N-terminal 25 amino acids of the extended homology
region (Figure 1B) were first noted by Koonin et al.
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(1994) to contain a consensus sequence of a putative
RNA-binding motif. Our data establish the 15.5kD protein
as a new member of this protein family that can interact
directly with RNA. Moreover, by introducing point
mutations into the 15.5kD protein, we show that two
highly conserved amino acids of the central 56 amino
acid homology region (G38 and A57) contribute to its
RNA-binding activity; mutation of these residues abolishes
binding (Figure 4A). In addition, mutation of residue Y80
within the homology region also significantly reduces
RNA-binding activity, but does not abolish it (Figure 4A).
In summary, the results discussed above suggest that the
56 amino acid region shared by the proteins listed in
Figure 1B may indeed be a novel RNA recognition motif.
Although the RNA-binding motif appears to be essential,
it is not sufficient for the U4 snRNA-binding activity of
the 15.5kD protein, i.e. a deletion mutant of the 15.5kD
protein lacking 33 amino acids at its C-terminus was no
longer capable of binding the U4 snRNA (Figure 4A).
Moreover, the entire 15.5kD protein was strongly protected
from proteolytic cleavage only when it was bound to
RNA, strengthening the idea that not only the conserved
RNA recognition motif, but also its flanking N- and
C-terminal regions contribute to U4 snRNA-binding
activity. The results of the limited proteolysis studies
may also indicate that the 15.5kD protein undergoes a
conformational change upon RNA binding. As unbound
15.5kD protein shows a high protease susceptibility, it is
possible that the structure of the free protein might be
partially or entirely disordered, but becomes stably folded
when it is bound specifically to RNA, resulting in increased
resistance to proteases. This kind of RNA-induced protein
folding has been described for several protein–RNA com-
plexes, including the bacteriophage λN-protein–boxB
RNA complex (Zheng and Gierasch, 1997) and the Ffh–
4.5S RNA interaction (Mogridge et al., 1998).
Functional importance of the U4 snRNA–15.5kD
protein interaction for splicing
Our finding that the 15.5kD protein interacts directly with
the U4 snRNA 5 stem–loop is not only interesting from
a structural point of view, but also provides a key to
understanding further the function of U4 snRNA in pre-
mRNA splicing. The essential role of the U4 snRNA 5
stem–loop in pre-mRNA splicing, as previously demon-
strated by mutagenesis experiments (see Introduction),
can now be attributed to the pivotal role that it plays in
15.5kD protein binding. The requirement for this stem–
loop for 15.5kD protein binding not only explains the
inhibitory effects observed with U4 snRNA mutants lack-
ing the entire 5 stem–loop (Bordonne´ et al., 1990; Wersig
and Bindereif, 1992), but also those obtained with certain
U4 snRNA point mutants. For example, it has been shown
that the 5 stem–loop triple mutation A30C, U31G and
G32U completely abolishes pre-mRNA splicing in a
splicing complementation assay carried out in Xenopus
oocytes (Vankan et al., 1992). Moreover, pre-mRNA
splicing was also inhibited in vivo and in vitro when the
yeast U4 snRNA contained a point mutation at position
45 (A45C; Hu et al., 1995). We demonstrate here that
mutation of the corresponding nucleotides within the
human U4 snRNA 5 stem–loop abolishes binding of the
15.5kD protein (Figure 3, see U4SL A44C and U4SL
S.Nottrott et al.
triple mutant). Curiously, a U4 snRNA 5 stem–loop
mutant where the loop sequence G45C46C47 has been
replaced byU45A46A47 still supported splicing inX.laevis
oocytes (Vankan et al., 1992). Consistent with the results
obtained with other mutants shown in Figure 3C, a U4SL
oligonucleotide containing the U45A46A47 sequence was
indeed inactive in 15.5kD protein binding (data not shown).
Additional studies are thus needed to clarify whether
under splicing conditions the integration of the 15.5kD
protein into U4 snRNPs is stabilized by protein–protein
interactions with other U4 snRNP or tri-snRNP proteins
when the strength of interaction between the 15.5kD
protein and its cognate U4 snRNA-binding site is signific-
antly lowered or abolished.
In this study we have investigated the functional impor-
tance of the 15.5kD–U4 snRNA 5 stem–loop interaction
in pre-mRNA splicing using an alternative approach.
Addition of an RNA oligonucleotide comprising the
human, wild-type U4 snRNA 5 stem–loop (human U4SL)
to HeLa cell nuclear extracts blocked the first step of pre-
mRNA splicing. Moreover, our observation that the U4atac
stem–loop oligonucleotide which binds the 15.5kD protein
more efficiently than the U4SL oligonucleotide also
inhibits pre-mRNA splicing more efficiently than U4SL
(Figure 5) indicates that the U4 stem–loop oligonucleotides
specifically sequester the 15.5kD protein. This idea is
supported further by the finding that splicing inhibition
could be rescued by the addition of purified 15.5kD protein
(Figure 5). Analysis of spliceosome assembly revealed
that C complex formation was inhibited specifically, while
B complexes accumulated under the same conditions
(Figure 6). Our results thus suggest that the U4SL oligonu-
cleotide interferes with the function of the 15.5kD protein
at a late stage of spliceosome assembly, after the [U4/
U6·U5] tri-snRNP has been integrated into the spliceo-
some, but prior to the first catalytic step. Consistent with
this interpretation, the addition of human U4SL to purified
[U4/U6·U5] tri-snRNPs did not disrupt the integrity of
the tri-snRNP (data not shown). It is therefore reasonable
to assume that upon integration of the tri-snRNP complex
into the spliceosome, conformational rearrangements
occur, rendering the 15.5kD protein accessible to displace-
ment by the U4SL oligonucleotide. This notion is corrobor-
ated strongly by our finding that the 15.5kD protein
becomes accessible to anti-15.5kD antibodies after integra-
tion of the tri-snRNP complex into the spliceosome, while
it remains inaccessible in the purified tri-snRNP complex
(Figure 7). Similarly, mutation of A45 to C in the 5
stem–loop of the yeast U4 snRNA, which is critical for
15.5kD protein binding in the human system (see above),
also led to the accumulation of spliceosomal B complexes
in vitro, accompanied by an inhibition of the first step of
splicing (Hu et al., 1995).
The activation of the spliceosome for the first step of
splicing requires the unwinding of the U4/U6 RNA duplex
(see Introduction). One possible explanation of our results
is that this unwinding step is inhibited due to the sequester-
ing of the 15.5kD protein by the U4SL RNA oligonucleo-
tide. However, we cannot distinguish between a direct or
indirect role of the 15.5kD protein in the B to C complex
transition. In particular, the observed inhibition of C
complex formation may also be due to co-sequestering of
additional U4 snRNP proteins by human U4SL which
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might be directly associated with the 15.5kD protein.
Candidates for such proteins are the 20/60/90kD protein
heteromer which is associated with the purified U4/U6
snRNP complex and for which no direct RNA interaction
has yet been demonstrated (see Introduction). Interestingly,
a mutation in one WD40 repeat of the U4 snRNP-
associated yeast protein Prp4p (counterpart of the human
60kD protein, see Introduction) has been shown to lead
to an accumulation of spliceosomal B complexes and to
the inhibition of the U4/U6 snRNA unwinding step (Ayadi
et al., 1997). It is thus possible that the 15.5kD protein
might act as a nucleation factor for the assembly of
additional U4 snRNP proteins, i.e. the 20/60/90kD heter-
omer. In summary, complex formation of the 15.5kD
protein and additional U4 snRNP proteins with the stem–
loop of U4 snRNA may be important to maintain a U4
snRNA conformation that is active in the concerted
protein-mediated structural changes of the U4 and U6
snRNAs prior to splicing catalysis. It will be very interest-
ing to define in future studies the exact composition of
the spliceosomal complex B which accumulates in the
presence of the human U4SL RNA oligonucleotide in vitro.
Future studies will also provide further insights into the
protein composition of the U4atac/U6atac RNP complex.
The results presented here indicate that the 15.5kD protein
is probably also present in the [U4atac/U6atac·U5] tri-
snRNP. If the 15.5kD protein acts as a nucleation factor
for the assembly of additional U4 snRNP proteins, it is
likely that the 20/60/90kD proteins of the major U4/
U6 snRNP complex are also shared by the U4atac/
U6atac snRNP.
Materials and methods
Isolation and cDNA cloning of the 15.5kD protein
Nuclear extracts were prepared from HeLa cells (Computer Cell Culture,
Mons, Belgium) according to Dignam et al. (1983) and UsnRNP particles
were purified by affinity chromatography using the monoclonal antibody
H20 as described (Lauber et al., 1996). Preparative amounts of 25S
[U4/U6·U5] tri-snRNP were isolated by centrifugation of the snRNP
mixture on a 10–30% glycerol gradient according to Laggerbauer et al.
(1996). Isolation of the 15.5kD [U4/U6·U5] tri-snRNP protein for
microsequencing was performed as described (Lauber et al., 1996).
Partial amino acid sequences of tryptic peptides of the 15.5kD protein
were determined by microsequencing on an ABI 477A protein sequencer
(Harvard Microchemistry Facility, Cambridge, USA). The peptide
sequences obtained were: (i) ADVN; and (ii) ACGVSRPVIACSVTI.
An EST derived from adult human breast tissue (DDBJ/EMBL/GenBank
accession No. R72749) whose ORF contained both partial peptide
sequences was obtained commercially. A HeLa cell cDNA library was
constructed using a cDNA synthesis kit as described by the manufacturer
(Stratagene). A DNA fragment containing the coding region of EST
R72749 was generated by PCR using gene-specific primers (15.5kD
FOR and 15.5 REV, see below). Recombinant phages were screened on
duplicate filters with the 32P-labelled coding region of EST R72749 by
standard methods (Sambrook et al., 1989) and positive phages were
purified by two additional rounds of screening. The sequence analysis
of the isolated 1.5 kb HeLa cDNA insert was performed as described
previously (Lauber et al., 1996). The sequence of the human 15.5kD
protein has been submitted to the DDBJ/EMBL/GenBank database under
accession No. AF155235.
Antibody production and Western blot analysis
BamHI and SalI restriction sites were added by PCR to the ORF of EST
R72749 using the gene-specific primers 15.5kD FOR and 15.5kD
REV (see below). The fragment was then subcloned into pGEX 4T-2
(Pharmacia) and recombinant GST–15.5kD fusion protein was purified
from Escherichia coli BL21 cells under native conditions using
glutathione–Sepharose as described by the manufacturer (Pharmacia).
Interaction of a novel tri-snRNP protein with U4 snRNA
Antibodies against GST–15.5kD were raised by immunization of New
Zealand white rabbits as described (Lauber et al., 1996). For Western
blot analysis, proteins were separated on a 13% SDS–polyacrylamide
gel, transferred to nitrocellulose and subsequently immunostained using
the ECL-Detektion Kit as described by the manufacturer (Amersham).
GST–15.5kD pull-downs
A 50 μg aliquot of either GST or GST–15.5kD fusion protein was
coupled to 30 μl of pre-swollen glutathione–Sepharose beads (Pharmacia)
in 500 μl of buffer A [20 mM HEPES–KOH (pH 7.9), 150 mM KCl,
1.5 mM MgCl2, 0.2 mM EDTA, 0.1% Triton X-100] for 2 h at 4°C.
The beads were then washed twice with buffer A, resuspended in 500 μl
of the same buffer and incubated for 2 h at 4°C with 2.5 μg of the
spliceosomal snRNA mixture in the presence of 50 μg of E.coli tRNA
(Boehringer Mannheim) and 50 μg of heparin (Sigma). The snRNAs
were obtained from immunoaffinity-purified snRNP particles by phenol
extraction at 0°C as described previously (Bringmann et al., 1984). For
the experiment in Figure 2A, lane 4, the UsnRNA mixture was denatured
by incubation for 1 min at 90°C and subsequently placed on ice prior
to use. After the incubation, the beads were washed three times with
buffer A and resuspended in 200 μl of the same buffer. UsnRNAs were
extracted with phenol and precipitated from the aqueous phase with
ethanol. The precipitated snRNAs subsequently were 3-end-labelled
with [5-32P]pCp (3000 Ci/mmol; Amersham), separated on a 10%
polyacrylamide–8 M urea gel and visualized by autoradiography.
In vitro transcription and translation of the 15.5kD protein
The plasmid containing the cDNA encoding the human 15.5kD protein
was linearized with XhoI (New England Biolabs) and transcribed with
T3 RNA polymerase (Promega) in a final volume of 50 μl. After phenol
extraction and ethanol precipitation, 1 μg of in vitro transcribed mRNA
was translated with wheat germ extract (Promega) in the presence of
[35S]methionine (1000 Ci/mmol; Amersham) in a total volume of 75 μl
according to the manufacturer (Promega).
Immunoprecipitations
For the co-immunoprecipitations shown in Figures 2A (lower panel) and
4A, 250 μg of monoclonal antibody H20 (Bringmann et al., 1983) was
coupled to 30 μl of pre-swollen protein A–Sepharose beads (Pharmacia)
in 400 μl of phosphate-buffered saline (PBS; pH 8.0) at 4°C overnight.
The beads were washed three times with IPP buffer [20 mM Tris–HCl
pH 8.0, 150 mM NaCl, 0.05% (v/v) NP-40] and resuspended in 300 μl
of the same buffer. A 15 μl aliquot of standard in vitro translation
reactions (see above) was incubated with 420 ng of m7G-capped, in vitro
transcribed UsnRNAs in 100 μl of buffer A for 1 h at 4°C. The in vitro
reconstitution mixture was then incubated with the protein A–Sepharose–
antibody conjugate for 1 h at 4°C. The beads were washed three times
with IPP buffer, dried and heated for 5 min at 90°C in 30 μl of SDS–
PAGE loading buffer. Co-immunoprecipitated protein was separated
on a 13% SDS–polyacrylamide gel and subsequently visualized by
autoradiography.
For the immunoprecipitation experiments shown in Figure 7, protein
A–Sepharose–antibody conjugates were first prepared as described
(Lauber et at., 1996). A 20 μl aliquot of protein A–Sepharose and either
20 μl of anti-15.5kD antiserum, 20 μl of control non-immune serum or
5 μl of Y12 antibody was used per reaction. Immunoprecipitation was
then performed by incubating the various samples is a total volume of
400 μl of PBS pH 8.0 for 2 h at 4°C with head-over-tail rotation.
Subsequently, the beads were washed four times with IPP buffer and
after the last washing step beads were processed as described below.
For the experiment in Figure 7A, protein A–Sepharose–antibody conjug-
ates were incubated with 10 μl of a standard in vitro translation reaction
(see above). The immunoprecipitated, 35S-labelled 15.5kD protein was
released from the beads by heating for 5 min at 90°C in 30 μl of SDS–
PAGE loading buffer, separated on a 13% SDS–polyacrylamide gel and
visualized by autoradiography. For immunoprecipitation of tri-snRNP
(Figure 7B), 5 μg of gradient-purified HeLa [U4/U6·U5] tri-snRNP was
incubated with the various protein A–Sepharose–antibody conjugates.
UsnRNAs were released from the beads by phenol extraction, 3-end-
labelled and analysed as above. For immunoprecipitation of spliceosomes
(Figure 7C), protein A–Sepharose–antibody conjugates were added to
the splicing reaction aliquots (see below). 32P-Labelled RNA was
released from the beads by phenol extraction.
Purification of recombinant 15.5kD protein
The concentration of recombinant GST–15.5kD protein purified from
E.coli BL21 cells was adjusted to 2 mg/ml to prevent precipitation of
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the protein during proteolytic cleavage. Cleavage of the GST–15.5kD
fusion protein was performed at room temperature for 12 h using 10 U
of thrombin (Pharmacia) per 1 mg of protein. To separate GST and
thrombin from the 15.5kD protein, the reaction mixture was applied
directly onto a gel filtration column (Superdex 75, 26/60, Pharmacia)
equilibrated with buffer B [20 mM HEPES–KOH pH 7.6, 120 mM
NaCl, 2 mM dithiothreitol (DTT)]. The elution of the protein was
monitored at 215 nm. Peak fractions were pooled and protein was
concentrated by ultrafiltration (Amicon, 10kD cut-off) to ~10 mg/ml.
With a calculated mol. wt of 14 174 Da for the 15.5kD protein, this
stock solution had a concentration of ~0.7 mM.
Hydroxyl radical footprinting
In vitro transcribed, 32P-labelled U4 snRNA (0.6 pmol) was incubated
for 1 h at 4°C with increasing amounts of recombinant 15.5kD protein
(0.3, 0.6, 3, 6, 33 and 134 pmol) in a final volume of 10 μl of buffer
A. Ribose cleavage of the RNA backbone was initiated by hydroxyl
radicals generated from H2O2 and free Fe(II)-EDTA complexes as
previously described (Hartmuth et al., 1999). The cleavage products
were analysed by primer extension using a 32P-labelled oligonucleotide
complementary to nucleotides 65–82 of human U4 snRNA (Oligo B1,
see below). The primer extension analysis was performed as described
(Hartmuth et al., 1999).
Electrophoretic mobility shift assay (EMSA) and competition
studies
RNA oligonucleotides were obtained commercially from Eurogentech
(Belgium) or from the microchemistry laboratory at the IMT (M. Krause,
Marburg). All RNA oligonucleotides were gel purified before use. The
RNA oligonucleotides were 5-end-labelled using [γ-32P]ATP (5000 Ci/
mmol; Amersham). Recombinant 15.5kD protein was incubated at a
final concentration of 14 μM with 0.5 pmol of RNA oligonucleotide for
1 h at 4°C in the presence of 10 μg of E.coli tRNA (Boehringer) and
in a final volume of 10 μl of buffer A. RNA and RNA–protein complexes
subsequently were resolved on a native 10% (80:1) polyacrylamide gel
containing 0.5 TBE and visualized by autoradiography. The amount
of shifted RNA was quantified by Phosphorimager analysis. For the
competition studies, recombinant 15.5kD protein (10 pmol) was pre-
incubated with increasing amounts of RNA oligonucleotides (5, 50, 100
and 250 pmol) for 20 min on ice before it was incubated for 45 min at
4°C with U4 snRNA (40 fmol) in a final volume of 10 μl of buffer A
and in the presence of 10 μg of E.coli tRNA (Boehringer Mannheim).
The protein–RNA complexes were analysed by EMSA as above except
that a 6% polyacrylamide gel was used. The U4 snRNA used was
in vitro transcribed in the presence of [α-32P]UTP (3000 Ci/mmol;
Amersham) and gel purified.
Site-directed mutagenesis
The QuickChange site-directed mutagenesis method (Stratagene) was
used to introduce the point mutations G38K (GGA to AAA), A57F
(GCT to TTT) and Y80A (TAC to GTT) into the 15.5kD protein, as well
as to delete the C-terminal 33 amino acids (Δ33). Two oligonucleotides
primers, each complementary to opposite strands of the 15.5kD protein
and containing the desired mutation, were designed (oligos 1A–4B, see
below) and mutagenesis was performed as described by the manufacturer.
The PCR cycling parameters were as follows: one cycle (30 s at 95°C),
16 cycles (30 s at 95°C, 1 min at 55°C and 9 min at 68°C), using native
Pfu DNA polymerase (New England Biolabs). The complete coding
sequence of all mutant clones was verified by DNA sequencing.
Proteolytic digestion experiments
In vitro reconstitution of the 15.5kD–RNA oligonucleotide complex was
carried out with 3 μg of purified recombinant protein and a 5-fold
excess of RNA oligonucleotide (U4atac SL and U4SL triple mutant,
respectively) in a final volume of 10 μl of buffer A for 1 h at 4°C. A
3 μg aliquot of either purified 15.5kD protein or in vitro reconstituted
15.5kD–RNA complex was incubated at 37°C with endoprotease Lys-C
(sequencing grade, Roche, EC 2.4.21.50), Glu-C (sequencing grade,
Roche, EC 3.4.21.19), chymotrypsin (sequencing grade, Roche, EC
3.4.21.1) or trypsin (sequencing grade, Promega, EC 3.4.21.4) with an
enzyme to substrate ratio of 1:20. The reactions were stopped after
1 min, 30 min, 2 h and 16 h by adding 3 vols of SDS–PAGE sample
buffer and heating for 5 min at 95°C. Aliquots of the reactions were
loaded onto a 16.6% Tris–Tricine gel (Scha¨gger and von Jagow, 1987)
and protein fragments were visualized by silver staining.
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In vitro splicing
Splicing was performed with 32P-labelled pre-mRNA derived from the
adenovirus major late transcription unit (pMINX; Zillmann et al., 1988).
The pre-mRNA was transcribed in vitro with [α-32P]UTP (3000 Ci/
mmol; Amersham) as described (Will et al., 1996). Standard splicing
assays contained 5 μl of HeLa cell nuclear extract (40% final concentra-
tion) in buffer D (Dignam et al., 1983), 40 mM KCl, 3 mM MgCl2,
2 mM ATP, 20 mM creatine phosphate and 32P-labelled pre-mRNA
(3 104 c.p.m., 25 fmol) in a final volume of 12.5 μl. For the experiment
in Figure 5, the splicing reaction mixtures were incubated for 60 min at
30°C in the presence of increasing amounts of RNA oligonucleotides
(20, 40, 80, 160 and 240 pmol). Recombinant 15.5kD protein was added
to the in vitro splicing reaction to 8, 18, 36 or 56 μM final concentration.
For the experiment in Figure 7C, a 300 μl standard splicing reaction
mixture was prepared and incubated at 30°C. After 0, 1, 5, 10, 20, 40
and 60 min incubation, three 12.5 μl aliquots were withdrawn, mixed
with 1.25 μl of heparin (5 mg/ml), incubated for an additional 5 min at
30°C and subsequently placed on ice. After completion of the time
course, 32P-labelled RNA was recovered from one aliquot of each
time point by phenol extraction and ethanol precipitation. Protein A–
Sepharose–antibody conjugates containing anti-15.5kD antiserum or
non-immune antiserum were added to the remaining aliquots. Co-
immunoprecipitation and RNA recovery were performed as described
above. All RNA samples were then analysed on a 14% polyacrylamide–
8 M urea gel.
Analysis of splicing complex formation
Standard splicing reactions were carried out as described above in a
final volume of 50 μl with or without 250 pmol of RNA oligonucleotide
(see figure legend for detail). After 0, 5, 10 and 20 min incubation at
30°C, a 10 μl aliquot of the splicing reaction was mixed with 2 μl of
heparin (5 mg/ml) and 2 μl of 87% glycerol and placed on ice. Splicing
complexes were separated on a 3.75% composite gel as described
(Behrens et al., 1993) and visualized by autoradiography.
DNA oligonucleotides used in this work
Primer 15.5kD FOR, 5-GGGGATCCATGACTCAGGCTGATGT-
GA-3; Primer 15.5kD REV, 5-TTGTCGACGGCAAGGGAAGC-
AACTTGGC-3. The BamHI and SalI sites are underlined. Oligo 1A
(G38K), 5-GGTGGCCTCATTGGCTTTTTTCCGAAGCTGCTT-3;
Oligo 1B (G38K), 5-AAGCAGCTTCGGAAAAAAGCCAATGAGG-
CCACC-3; Oligo 2A (A57F), 5-GAGTTCATCGTGAT- ATTTGC-
AGACGCCGAGCCA-3; Oligo 2B (A57F), 5-TGGCTCGGCGT-
CTGCAAACATCACGATGAACTC-3; Oligo 3A (Y80A), 5-GACAA-
GAATGTGCCCGCCGTGTTTGTGCGCTCC-3; Oligo 3B (Y80A),
5-GGAGCGCACAAACACGGCGGGCACATTCTTGTC-3; Oligo 4A
(del33), 5-TTACACTAAGAGCCTTCTCCCCAGGGCCTG CTT-
GG-3; Oligo 4B (del33), 5-CCAAGCAGGCCCTGGGGAGAAGGCT-
CTTAGTGTAA-3; Oligo B1, 5-GGTATTGGGAAAAGTTT-3.
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